Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Defense was posted on September 3, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

FDA-Approved Radiopharmaceutical Supplies and Cold Kits

Closed
HT9406-26-Q-E102Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Defense Health Agency is soliciting a firm-fixed-price contract for the continuous provision, custom compounding, and timely delivery of 61 FDA-approved radiopharmaceuticals and cold kits to the Nuclear Medicine Section at the Dwight David Eisenhower Army Medical Center (DDEAMC) in Fort Gordon, Georgia. The contract structure consists of a one-year base period and four optional one-year extensions, running through September 30, 2031. The contractor is responsible for providing all necessary personnel, equipment, and transportation to ensure the delivery of these short half-life materials, including the capability to execute emergency deliveries within two hours of order acceptance on a 24/7/365 basis. Award will be based on the Lowest Price Technically Acceptable (LPTA) process. To be deemed technically acceptable, offerors must possess an active NRC or Agreement State radioactive materials license, FDA Blood Establishment compounding registration, and CLIA certifications. Additionally, the compounding pharmacy must be located within a 90-minute driving radius of DDEAMC to meet strict 30-minute pre-calibration delivery windows. All operations must strictly adhere to FDA, NRC, DOT, and HIPAA regulations, with 100 percent inspection upon receipt by medical staff. Payment will be processed via Electronic Funds Transfer through the Wide Area Workflow system.

General Info

DHA seeks radiopharmaceuticals and cold kits for Eisenhower Army Medical Center by September 2026.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Fort Gordon, GA, 30905, USA

Set-Aside

NONE

Documents

4

HT940626 Q-E102 Combined Synopsis/Solicitation RFQ

PDF, High priority: read this first14 pages · rfq
High

HT940626QE102 Pricing Sheet Attachment

XLSX, High priority: read this first6 pages · pricing-sheet
High

HT9406-26-Q-E102 Questions and Answers

PDF, High priority: read this firstq-and-a
High

Performance Work Statement - FDA-Approved Radiopharmaceutical Supplies

PDF, High priority: read this first8 pages · sow
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseClosed
Posted

Combined Synopsis

Notice updated

Notice details unchanged. Attachments may have changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
Contacts2 people available
OfficeFREDERICK, MD, 21702, USA
Office AddressFREDERICK, MD, 21702, USA
Contacts
Lenore Y. Paseda

Full Description

Show more

The Contractor shall provide all personnel, equipment, supplies, facilities, transportation, tools, materials, supervision, and other items and non-personal services necessary to ensure the continuous provision, custom compounding, and timely delivery of FDA-approved radiopharmaceuticals and cold kits to the Nuclear Medicine Section at the Dwight David Eisenhower Army Medical Center (DDEAMC), Fort Gordon, Georgia.

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

NAICS: 811210
New
Federal
Zeiss Meditec Ophthalmology Equipment Maintenance
Solicitation # HT940627QE003
Solicitation HT940627QE003 is a Request for Quote issued by the Defense Health Agency, Healthcare Contracting Division-Southeast, for a firm-fixed-price contract to provide full-service maintenance for Zeiss MediTec ophthalmology equipment at the Naval Medical Center Camp Lejeune in North Carolina. The scope of work includes regularly scheduled preventative maintenance, timely onsite repairs, and software updates for specific devices, including the CIRRUS 5000, IOLMASTER 700, HFA3 B60, and ATLAS 900. All services must be performed according to manufacturer recommendations and applicable FDA regulations. The contract consists of a base period from December 1, 2026, to November 30, 2027, with four subsequent option periods extending the potential performance through November 30, 2031. This procurement is a total small business set-aside under NAICS code 811210. Award will be made based on the Lowest Priced Technically Acceptable (LPTA) basis, where technical capability is evaluated independently of price. Offerors must submit two separate volumes: Volume I for technical capability, which must describe the functional approach and methodology without identifying company names or logos, and Volume II for comprehensive pricing. Quotes are due by 8:00 am Eastern Time on October 29, 2026. Payment and invoicing will be processed electronically through the Wide Area WorkFlow system.
Electronic and Precision Equipment Repair and Maintenance

POSTED

1 day ago

DEADLINE

in 9 days
View Details
NAICS: 541715
New
Federal
Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
Solicitation # HT9427-26-R-E020
The Defense Health Agency Contracting Activity is seeking a single award for the development of a Battlefield Wound Infection Prevention and Treatment Barrier Combination prototype. This product must integrate a physical wound barrier with antimicrobial and antifungal properties to prevent the spread of organisms and systemic infections in combat scenarios. The project aims to advance technologies from a preferred Technology Readiness Level of 5 or higher to a final state of TRL 7 or 8, culminating in mandatory U.S. Food and Drug Administration approval or clearance. The scope of work includes preclinical testing, human clinical trials, and the submission of regulatory packages such as New Drug Applications or Premarket Approval Applications. This procurement is conducted under prototype Other Transaction Authority 10 U.S.C. 4022, meaning standard FAR and DFARS regulations do not apply unless expressly referenced. The estimated period of performance is 48 months, divided into three primary objectives: prototype demonstration, clinical studies and regulatory submissions, and final FDA clearance. Proposals are due by November 6, 2026, and must be submitted in three distinct volumes covering technical approach, management capability, and administrative cost and price. To be eligible, offerors must be registered in the System for Award Management and meet specific criteria, such as being a nontraditional defense contractor or a small business.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

1 day ago

DEADLINE

in 17 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS